Literature DB >> 7876456

Interrater reliability of the DSM-III-R with preschool children.

J V Lavigne1, R Arend, D Rosenbaum, J Sinacore, C Cicchetti, H J Binns, K K Christoffel, J R Hayford, P McGuire.   

Abstract

Little attention has been paid to evaluating the use of DSM-III-R with preschool children. Children (N = 510) ages 2 to 5 years who were screened at the time of a pediatric visit were selected to participate in an evaluation which included questionnaires, a semistructured interview, developmental testing, and a play observation. Following the evaluation, two clinical child psychologists independently assigned DSM-III-R diagnoses. For each diagnostic category, kappa and Y coefficients were calculated; Y coefficients are less sensitive to base rates of disorders. For overall agreement, the weighted mean kappa (.61), and mean Y (.66) were moderately high. Overall agreement that the child had at least one of the disruptive disorders was substantial (kappa = .64; Y = .65); agreement that there was at least one of the emotional disorders was moderate for kappa (.54), but substantial for Y (.70). Kappa coefficients were higher for major categories of disorder than for specific disorders; however, Y coefficients did not show a decline for specific disorders. Interrater reliability of DSM-III-R appears to be similar for preschoolers and older children.

Entities:  

Mesh:

Year:  1994        PMID: 7876456     DOI: 10.1007/bf02171995

Source DB:  PubMed          Journal:  J Abnorm Child Psychol        ISSN: 0091-0627


  19 in total

1.  Diagnostic continuity from preschool to middle childhood.

Authors:  J H Beitchman; C Wekerle; J Hood
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1987-09       Impact factor: 8.829

2.  DSM-III diagnostic classification of 100 preschoolers in a child development unit.

Authors:  J H Kashani; E Horwitz; J S Ray; J C Reid
Journal:  Child Psychiatry Hum Dev       Date:  1986

3.  DSM-III field trials: I. Initial interrater diagnostic reliability.

Authors:  R L Spitzer; J B Forman; J Nee
Journal:  Am J Psychiatry       Date:  1979-06       Impact factor: 18.112

4.  Multidisciplinary evaluation of preschool children and its demography in a military psychiatric clinic.

Authors:  B J Lee
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1987-05       Impact factor: 8.829

5.  A proposed solution to the base rate problem in the kappa statistic.

Authors:  E L Spitznagel; J E Helzer
Journal:  Arch Gen Psychiatry       Date:  1985-07

6.  A comparison of DSM-II and DSM-III in the diagnosis of childhood psychiatric disorders. II. Interrater agreement.

Authors:  R Mattison; D P Cantwell; A T Russell; L Will
Journal:  Arch Gen Psychiatry       Date:  1979-10

7.  A comparison of DSM-II and DSM-III in the diagnosis of childhood psychiatric disorders. I. Agreement with expected diagnosis.

Authors:  D P Cantwell; A T Russell; R Mattison; L Will
Journal:  Arch Gen Psychiatry       Date:  1979-10

8.  The interrater reliability of DSM III in children.

Authors:  J S Werry; R J Methven; J Fitzpatrick; H Dixon
Journal:  J Abnorm Child Psychol       Date:  1983-09

Review 9.  Child psychiatric disorders: are they classifiable?

Authors:  J S Werry
Journal:  Br J Psychiatry       Date:  1992-10       Impact factor: 9.319

10.  Reliability of psychiatric diagnosis in hospitalized adolescents. Interrater agreement using DSM-III.

Authors:  M Strober; J Green; G Carlson
Journal:  Arch Gen Psychiatry       Date:  1981-02
View more
  2 in total

1.  Predictors and correlates of completing behavioral parent training for the treatment of oppositional defiant disorder in pediatric primary care.

Authors:  John V Lavigne; Susan A Lebailly; Karen R Gouze; Helen J Binns; Jennifer Keller; Lindsay Pate
Journal:  Behav Ther       Date:  2009-12-05

2.  Retest stability of DSM-III-R diagnoses among adolescents using the Diagnostic Interview Schedule for Children (DISC-2.1C).

Authors:  R E Roberts; B L Solovitz; Y W Chen; C Casat
Journal:  J Abnorm Child Psychol       Date:  1996-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.